Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
BJU International
|
September 8, 2007
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy
Mark I Johnson, David Merrilees, Wendy A Robson, et al.
Asian Journal of Andrology
|
December 4, 2008
Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors
Joseph Nariculam, Alex Freeman, Simon Bott, et al.
BJU International
|
November 8, 2008
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial
Nicholas D James, Matthew R Sydes, Noel W Clarke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2013
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging
Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.
Oncotarget
|
October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
Helen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
BJU International
|
September 8, 2007
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy
Mark I Johnson, David Merrilees, Wendy A Robson, et al.
Asian Journal of Andrology
|
December 4, 2008
Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors
Joseph Nariculam, Alex Freeman, Simon Bott, et al.
BJU International
|
November 8, 2008
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial
Nicholas D James, Matthew R Sydes, Noel W Clarke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2013
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging
Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.
Oncotarget
|
October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
Helen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Page
of 2